BioAdvance — 2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

Bainbridge Healthbainbridgehealth.com inJun 2018 · $1.6M

Bainbridge Health provides software solutions for hospital pharmacy operations, including infusion safety analytics, IV formulation management, and drug library development.

Data & InfrastructureDigital HealthEnterprise SoftwareHealthtechMedical DevicesPhiladelphia, US

Sam Wilson(Executive Officer)inJoseph Kaupp(Executive Officer, Director)Sean O'Neill(Executive Officer, Director)

BoardAmy Gallagher(Director)Shahram Hejazi(Director)Thomas Lynch(Director)

Co-investorsAlumni Ventures Chestnut Street Ventures

KaloCytekalocyte.com inApr 2018

KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply.

BiotechDeep TechHealthtechMedical DevicesBaltimore, US

Allan Doctor(Co-Founder & CSO)in Dipanjan Pan(Co-Founder, Chief Technical Officer)in Philip Spinella(Co-Founder, Chief Medical Officer)inDaniel Getman(Director)Gregory Lanza(Director)

Co-investorsBioGenerator Ventures Delaware Crossing Investor Group Maryland TEDCO NYBC Ventures Old Line Capital Partners TEDCO +1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.